HRSA: Reducing Loss to Follow-up after Failure to Pass Newborn Hearing Screening

by: Michael Saunders

The Health Resources and Services Administration, otherwise referred to as the HRSA, is the US government's leading agency designed to help citizens, specially the uninsured, isolated and medically vulnerable, in obtaining access to safe and cost-effective health care services.

The HRSA constantly works towards providing leadership and financial support to members of health care teams within the US and its territories, which is why they establish training programs for health professionals in rural communities in the hopes of tremendously improving their systems of care.

Conforming to the goals and objectives of the agency, HRSA has recently announced a new program called Reducing to Loss of Follow-up after Failure to Pass Newborn Hearing Screening program.

The aforementioned program enables eligible health care institutions to solicit funds by establishing project proposals that would greatly improve the number of infants receiving appropriate and timely follow-ups through the utilization of patient-centered interventions.

The Reducing to Loss of Follow-up after Failure to Pass Newborn Hearing Screening program is driven by the HRSA's willingness to encourage health care providers that the utilization of quality improvement methodology is vital in the process of identifying small programmatic changes that would result in documented improvements in infant/family outcomes.

  (continued...)

HRSA: Reducing Loss to Follow-up after Failure to Pass Newborn Hearing Screening
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Medical Tropical Research Laboratory Program Infectious Disease Research Award
AFRIMS has recently announced the WRAIR Medical Tropical Research Laboratory Program(MTRLP) Infectious Disease Research Award(IDRA), a funding opportunity which solicits proposals that aim to tackle basic, preclinical and clinical research of emerging infectious diseases in Thailand and a certain region in Southeast Asia.

---